Day One Biopharmaceuticals I share price logo

Day One Biopharmaceuticals I Share Price

NASDAQ: DAWN

Mid Cap

$21.38

+0.02

(+0.07%)

as on

Day One Biopharmaceuticals I Stock Performance

as on March 25, 2026 at 6:59 am IST

  • Day's Low

    $21.34
    $21.38
    downward going graph

    0.19%

    Downside

  • 52 Week's Low

    52 Week's High

    $5.64
    $21.44
    downward going graph

    73.64%

    Downside

    0.28%

    Upside

    downward going graph

Day One Biopharmaceuticals I share price movements today

Previous Close
$21.36
Open
$21.36
Volume
1.8M
Day's Low - High
$21.34 - $21.38
52 Week Low - High
$5.64 - $21.44

Day One Biopharmaceuticals I Historical Returns

1 Month Return
+ 95.43 %
3 Month Return
+ 122.5 %
1 Year Return
+ 157.97 %
3 Year Return
+ 39.43 %
5 Year Return
0 %

Day One Biopharmaceuticals I Stock Fundamentals & Key Indicators

Check Day One Biopharmaceuticals I market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.2B

EPS (TTM)

-0.7551

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-124.3M

Revenue (TTM)

158.2M

Profit Margin

-67.85%

Return On Equity TTM

-22.74%

Day One Biopharmaceuticals I vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Day One Biopharmaceuticals I with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Day One Biopharmaceuticals I image
Day One Biopharmaceuticals I
BUY$2.2BNANA-67.85%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B126.75%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.49%29.6832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B58.91%17.6731.41%

Stock Returns calculator for Day One Biopharmaceuticals I Stock including INR - Dollar returns

The Day One Biopharmaceuticals I stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Day One Biopharmaceuticals I investment value today

Current value as on today

₹2,67,753

Returns

₹1,67,753

(+167.75%)

Returns from Day One Biopharmaceuticals I Stock

₹1,58,213 (+158.21%)

Dollar Returns*

₹9,541 (+9.54%)

Analyst Recommendation on Day One Biopharmaceuticals I Stock

Based on 17 analysts

BUY

82.35%

Buy

11.76%

Hold

5.88%

Sell

Based on 17 analysts, 82.35% of analysts recommend a 'BUY' rating for Day One Biopharmaceuticals I. Average target price of $21.5

Day One Biopharmaceuticals I Share Price Target

Get share price movements and forecasts by analysts on Day One Biopharmaceuticals I.

What analysts predicted

0.56%UPSIDE

Target Price

$21.5

Current Price

$21.38

Analyzed by

17 Analysts

Target

$21.50

Day One Biopharmaceuticals I target price $21.5, a slight upside of 0.56% compared to current price of $21.38. According to 17 analysts rating.

Day One Biopharmaceuticals I Stock’s Investor Sentiment and Interest

Search interest for Day One Biopharmaceuticals I Stock has increased by 254% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:254% versus previous 30 day period

Day One Biopharmaceuticals I Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
0
-
8
93
29
30
33
39
53
Gross Profit
0
0
0
7
92
26
27
30
35
47
Operating Income
-51
-59
-66
-114
29
-65
-41
-34
-24
-27
EBITDA
-46
-54
-62
-2
36
-58
-35
-29
-18
-22
Interest Expense
-
3
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-46
-54
-62
-2
36
-59
-35
-30
-19
-23
Income Tax Expense
0
10
0
1
0
6
-
-
-
-1
Net Income
-46
-54
-62
-4
37
-65
-35
-30
-19
-21
Net Profit Margin
0.00%
-9734.11%
0.00%
-53.80%
39.50%
-224.99%
-117.02%
-89.42%
-49.57%
-39.61%

Day One Biopharmaceuticals I Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
131
158
Gross Profit
-
0
0
0
0
125
140
Operating Income
-14
-13
-72
-146
-206
-217
-127
EBITDA
0
-43
-72
-146
-188
-86
-105
Interest Expense
2
0
0
4
-
-
-
Depreciation
-
0
0
0
0
2
3
Income Before Tax
-16
-43
-72
-142
-188
-88
-109
Income Tax Expense
-2
-3
-2
-10
-
7
-1
Net Income
-12
-40
-70
-132
-188
-95
-107
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-72.81%
-67.85%

Day One Biopharmaceuticals I Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-54
-62
-4
37
-65
-35
-30
-19
-21
Operating Cash Flow
-41
-49
-49
50
-30
-58
-24
-5
-14
Investing Cash Flow
30
89
17
-67
-269
-32
26
13
167
Financing Cash Flow
0
0
1
200
1
-
0
0
0
Change in Cash
-10
39
-30
183
-297
-91
2
7
153

Day One Biopharmaceuticals I Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-43
-72
-142
-188
-95
-107
Operating Cash Flow
-13
-48
-109
-146
-78
-103
Investing Cash Flow
0
-8
-255
128
-230
174
Financing Cash Flow
29
297
165
163
203
1
Change in Cash
16
240
-199
145
-105
72

Global Institutional Holdings in Day One Biopharmaceuticals I

Funds
Holdings
Vestal Point Capital LP
5.03%
AIGH Capital Management, LLC
1.93%
Alyeska Investment Group, L.P.
2.94%
Geode Capital Management, LLC
1.71%
Balyasny Asset Management LLC
1.44%
See all

Day One Biopharmaceuticals I News & Key Events

  • img

    Today's Timeline - 11 January

    Mon, 03:30 AM

    -

    Day One announces preliminary 2025 net product revenue and provides 2026 guidance of $225-$250 million for Ojemda.

Insights on Day One Biopharmaceuticals I

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, DAWN has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, DAWN has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, DAWN stock has moved up by 95.4%

About Day One Biopharmaceuticals I

day one biopharmaceuticals understands that advances in cancer research now enable drug developers to identify children and adults who may benefit from the same medicine. we are a unique company created to find and develop new therapies that meet the critical needs of people of all ages living with cancer – starting from the biology of childhood cancer. our distinctive approach, together with our trusted network of pediatric oncology investigators, gives us an unparalleled ability to advance promising discoveries for patients of any age. we are ready to pursue the full potential of our therapies to improve the greatest number of lives as quickly as possible.
OrganisationDay One Biopharmaceuticals I
Headquarters1800 Sierra Point Parkway, Brisbane, CA, United States, 94005
IndustryHealthcare
CEODr. Jeremy Bender M.B.A., Ph.D.
E-voting on sharesClick here to vote

Key Management of Day One Biopharmaceuticals I

Name

Title

Dr. Heather Adkins Huet Ph.D.

Chief Scientific Officer

Mr. Joey Perrone

Senior Vice President of Finance & Investor Relations

Ms. Jaa Roberson

Chief People Officer

Ms. Lauren Merendino M.B.A.

Chief Commercial Officer

Dr. Elly Barry M.D.

Chief Medical Officer

Mr. Adam Dubow J.D.

General Counsel

Mr. John Stubenrauch Ph.D.

Chief Technology Officer

Dr. Davy Chiodin Ph.D., Pharm.D.

Chief Development Officer

Dr. Jeremy Bender M.B.A., Ph.D.

CEO, President & Director

Mr. Charles N. York II, M.B.A.

COO & CFO

FAQs

What is Day One Biopharmaceuticals I share price today?

Day One Biopharmaceuticals I share price today is $21.38 as on at the close of the market. Day One Biopharmaceuticals I share today touched a day high of $21.38 and a low of $21.34.

What is the 52 week high and 52 week low for Day One Biopharmaceuticals I share?

Day One Biopharmaceuticals I share touched a 52 week high of $21.44 on and a 52 week low of $5.64 on . Day One Biopharmaceuticals I stock price today i.e. is closed at $21.38,which is 0.28% down from its 52 week high and 279.41% up from its 52 week low.

What is Day One Biopharmaceuticals I's market capitalisation today?

Day One Biopharmaceuticals I market capitalisation is $0.00T as on .

How to invest in Day One Biopharmaceuticals I Stock (DAWN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Day One Biopharmaceuticals I on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Day One Biopharmaceuticals I Shares that will get you 0.0702 shares as per Day One Biopharmaceuticals I share price of $21.38 per share as on March 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Day One Biopharmaceuticals I Stock (DAWN) from India?

Indian investors can start investing in Day One Biopharmaceuticals I (DAWN) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Day One Biopharmaceuticals I stock (as per the Rupee-Dollar exchange rate as on ). Based on Day One Biopharmaceuticals I share’s latest price of $21.38 as on March 25, 2026 at 1:29 am IST, you will get 0.4677 shares of Day One Biopharmaceuticals I. Learn more about fractional shares .